Exemestan Stada is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breast cancer EBC, following 2 3 years of initial adjuvant tamoxifen therapy <a href=https://buylasixon.com/>bumex vs lasix</a>